Treace Medical Concepts Statistics
Total Valuation
TMCI has a market cap or net worth of $94.30 million. The enterprise value is $117.80 million.
Important Dates
The last earnings date was Friday, February 27, 2026, before market open.
| Earnings Date | Feb 27, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TMCI has 64.59 million shares outstanding. The number of shares has increased by 1.86% in one year.
| Current Share Class | 64.42M |
| Shares Outstanding | 64.59M |
| Shares Change (YoY) | +1.86% |
| Shares Change (QoQ) | +0.54% |
| Owned by Insiders (%) | 25.64% |
| Owned by Institutions (%) | 44.87% |
| Float | 47.32M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.44 |
| Forward PS | 0.45 |
| PB Ratio | 1.07 |
| P/TBV Ratio | 1.40 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.55 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.31, with a Debt / Equity ratio of 0.82.
| Current Ratio | 4.31 |
| Quick Ratio | 2.96 |
| Debt / Equity | 0.82 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -10.18 |
Financial Efficiency
Return on equity (ROE) is -58.94% and return on invested capital (ROIC) is -19.81%.
| Return on Equity (ROE) | -58.94% |
| Return on Assets (ROA) | -16.60% |
| Return on Invested Capital (ROIC) | -19.81% |
| Return on Capital Employed (ROCE) | -33.86% |
| Weighted Average Cost of Capital (WACC) | 7.34% |
| Revenue Per Employee | $472,644 |
| Profits Per Employee | -$131,116 |
| Employee Count | 450 |
| Asset Turnover | 1.04 |
| Inventory Turnover | 1.14 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -82.15% in the last 52 weeks. The beta is 0.77, so TMCI's price volatility has been lower than the market average.
| Beta (5Y) | 0.77 |
| 52-Week Price Change | -82.15% |
| 50-Day Moving Average | 2.17 |
| 200-Day Moving Average | 4.68 |
| Relative Strength Index (RSI) | 36.87 |
| Average Volume (20 Days) | 999,796 |
Short Selling Information
The latest short interest is 3.67 million, so 5.68% of the outstanding shares have been sold short.
| Short Interest | 3.67M |
| Short Previous Month | 3.56M |
| Short % of Shares Out | 5.68% |
| Short % of Float | 7.76% |
| Short Ratio (days to cover) | 5.61 |
Income Statement
In the last 12 months, TMCI had revenue of $212.69 million and -$59.00 million in losses. Loss per share was -$0.93.
| Revenue | 212.69M |
| Gross Profit | 169.75M |
| Operating Income | -54.15M |
| Pretax Income | -59.00M |
| Net Income | -59.00M |
| EBITDA | -44.53M |
| EBIT | -54.15M |
| Loss Per Share | -$0.93 |
Full Income StatementBalance Sheet
The company has $48.37 million in cash and $71.86 million in debt, with a net cash position of -$23.50 million or -$0.36 per share.
| Cash & Cash Equivalents | 48.37M |
| Total Debt | 71.86M |
| Net Cash | -23.50M |
| Net Cash Per Share | -$0.36 |
| Equity (Book Value) | 87.33M |
| Book Value Per Share | 1.37 |
| Working Capital | 101.42M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$15.97 million and capital expenditures -$13.52 million, giving a free cash flow of -$29.49 million.
| Operating Cash Flow | -15.97M |
| Capital Expenditures | -13.52M |
| Free Cash Flow | -29.49M |
| FCF Per Share | -$0.46 |
Full Cash Flow StatementMargins
Gross margin is 79.81%, with operating and profit margins of -25.46% and -27.74%.
| Gross Margin | 79.81% |
| Operating Margin | -25.46% |
| Pretax Margin | -27.74% |
| Profit Margin | -27.74% |
| EBITDA Margin | -20.94% |
| EBIT Margin | -25.46% |
| FCF Margin | n/a |
Dividends & Yields
TMCI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.86% |
| Shareholder Yield | -1.86% |
| Earnings Yield | -62.57% |
| FCF Yield | -31.27% |
Analyst Forecast
The average price target for TMCI is $4.77, which is 226.71% higher than the current price. The consensus rating is "Hold".
| Price Target | $4.77 |
| Price Target Difference | 226.71% |
| Analyst Consensus | Hold |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
TMCI has an Altman Z-Score of 1.38 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.38 |
| Piotroski F-Score | 2 |
